Murine and Human-Purified very Small Embryonic-like Stem Cells (VSELs) Express Purinergic Receptors and Migrate to Extracellular ATP Gradient.

Chemotaxis Extracellular ATP Extracellular Ado MCC950 Nlrp3 inflammasome Purinergic receptors VSELs

Journal

Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767

Informations de publication

Date de publication:
18 Apr 2024
Historique:
accepted: 29 03 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 18 4 2024
Statut: aheadofprint

Résumé

Purinergic signaling is an ancient primordial signaling system regulating tissue development and specification of various types of stem cells. Thus, functional purinergic receptors are present in several types of cells in the body, including multiple populations of stem cells. However, one stem cell type that has not been evaluated for expression of purinergic receptors is very small embryonic stem cells (VSELs) isolated from postnatal tissues. Herein, we report that human umbilical cord blood (UCB) and murine bone marrow (BM) purified VSELs express mRNA for P1 and P2 purinergic receptors and CD39 and CD73 ectonucleotidases converting extracellular ATP (eATP) into its signaling metabolite extracellular adenosine (eAdo), that antagonizes eATP effects. More importantly, we demonstrate that human and murine VSELs respond by chemotaxis to eATP, and eAdo inhibits this migration. These responses to eATP are mediated by activation of Nlrp3 inflammasome, and exposure of VSELs to its specific inhibitor MCC950 abolished the chemotactic response to ATP. We conclude that purinergic signaling plays an essential, underappreciated role in the biology of these cells and their potential role in response to tissue/organ injuries.

Identifiants

pubmed: 38635127
doi: 10.1007/s12015-024-10716-4
pii: 10.1007/s12015-024-10716-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Narodowe Centrum Nauki
ID : OPUS grant UMO-2021/41/B/NZ3/01589
Organisme : Narodowe Centrum Nauki
ID : OPUS grant UMO- 2022/45/B/NZ3/00476

Informations de copyright

© 2024. The Author(s).

Références

Burnstock, G. (2020). Introduction to purinergic signaling. Methods in Molecular Biology (Clifton, N.J.), 2041, 1–15.
doi: 10.1007/978-1-4939-9717-6_1 pubmed: 31646477
Burnstock, G., & Ulrich, H. (2011). Purinergic signaling in embryonic and stem cell development. Cellular and Molecular Life Sciences, 68, 1369–1394.
doi: 10.1007/s00018-010-0614-1 pubmed: 21222015
Linden, J., Koch-Nolte, F., & Dahl, G. (2019). Purine release, metabolism, and signaling in the inflammatory response. Annual Review of immunology, 37, 325–347.
doi: 10.1146/annurev-immunol-051116-052406 pubmed: 30676821
Franczak, S., Ulrich, H., & Ratajczak, M. Z. (2023). Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity. Purinergic Signaling. https://doi.org/10.1007/s11302-023-09943-0 . Advance online publication.
doi: 10.1007/s11302-023-09943-0
Ratajczak, M. Z., Bujko, K., Brzezniakiewicz-Janus, K., Ratajczak, J., & Kucia, M. (2024). Hematopoiesis revolves around the primordial evolutional rhythm of purinergic signaling and innate immunity – a journey to the developmental roots. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10692-9 . Online ahead of print.
doi: 10.1007/s12015-024-10692-9 pubmed: 38363476 pmcid: 10984895
Ratajczak, M. Z., Ratajczak, J., Suszynska, M., Mille, D. M., Kucia, M., et al. (2017). A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells. Circulation Research, 120, 166–178.
doi: 10.1161/CIRCRESAHA.116.309362 pubmed: 28057792 pmcid: 5221475
Kucia, M., Reca, R., Campbell, F. R., Zuba-Surma, E., Majka, M., Ratajczak, J., et al. (2006). A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia, 20, 857–869.
doi: 10.1038/sj.leu.2404171 pubmed: 16498386
Ratajczak, M. Z., Ratajczak, J., & Kucia, M. (2019). Very small embryonic-like stem cells (VSELs). Circulation Research, 124, 208–210.
doi: 10.1161/CIRCRESAHA.118.314287 pubmed: 30653438 pmcid: 6461217
Ratajczak, J., Wysoczynski, M., Zuba-Surma, E., Wan, W., Kucia, M., Yoder, M. C., et al. (2011). Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells. Experimental Hematology, 39, 225–237.
doi: 10.1016/j.exphem.2010.10.007 pubmed: 21034791
Domingues, A., Rossi, E., Bujko, K., Detriche, G., Richez, U., Blandinieres, A., et al. (2022). Human CD34+ very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acid. Leukemia, 36, 1440–1443.
doi: 10.1038/s41375-022-01517-0 pubmed: 35169243 pmcid: 9061289
Bhartiya, D., Anand, S., Kaushik, A., & Sharma, D. (2019). Stem cells in the mammalian gonads. Advances in Experimental Medicine and Biology, 1201, 109–123.
doi: 10.1007/978-3-030-31206-0_6 pubmed: 31898784
Bhartiya, D., Flora, Y., Sharma, D., & Mohammad, S. A. (2021). Two stem cell populations including VSELs and CSCs detected in the pericardium of adult mouse heart. Stem Cell Rev Rep., 17, 685–693.
doi: 10.1007/s12015-021-10119-9 pubmed: 33492626
Chen, Z. H., Lv, X., Dai, H., Liu, C., Lou, D., Chen, R., et al. (2015). Hepatic regenerative potential of mouse bone marrow very small embryonic-like stem cells. Journal of Cellular Physiology, 230, 1852–1861.
doi: 10.1002/jcp.24913 pubmed: 25545634
Ciechanowicz, A. K., Sielatycka, K., Cymer, M., Skoda, M., Suszyńska, M., Bujko, K., et al. (2021). Bone marrow-derived VSELs Engraft as lung epithelial progenitor cells after bleomycin-induced lung injury. Cells, 10, 1570.
doi: 10.3390/cells10071570 pubmed: 34206516 pmcid: 8303224
Kennedy, C. (2017). P2Y11 receptors: Properties. Distribution and functions. Advances in Experimental Medicine and Biology, 1051, 107–122.
doi: 10.1007/5584_2017_89 pubmed: 29134605
Bujko, K., Kucia, M., Ratajczak, J., & Ratajczak, M. Z. (2019). Hematopoietic stem and progenitor cells (HSPCs). Advances in Experimental Medicine and Biology., 1201, 49–77.
doi: 10.1007/978-3-030-31206-0_3 pubmed: 31898781
Rossi, L., Salvestrini, V., Ferrari, D., Di Virgilio, F., & Lemoli, R. M. (2012). The sixth sense: Hematopoietic stem cells detect danger through purinergic signaling. Blood, 120, 2365–2375.
doi: 10.1182/blood-2012-04-422378 pubmed: 22786880
Adamiak, M., Bujko, K., Thapa, A., Pensato, V., Brzezniakiewicz-Janus, K., Ratajczak, J., Davies, D. L., et al. (2022). The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking. Leukemia, 36, 248–256.
doi: 10.1038/s41375-021-01352-9 pubmed: 34285343
Thapa, A., Abdelbaset-Ismail, A., Chumak, V., Adamiak, M., Brzezniakiewicz-Janus, K., et al. (2022). Extracellular adenosine (eAdo) - A
doi: 10.1007/s12015-022-10417-w pubmed: 35870082 pmcid: 9622533
Adamiak, M., Bujko, K., Cymer, M., Plonka, M., Glaser, T., Kucia, M., et al. (2018). Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells. Leukemia., 32, 1920–1931.
doi: 10.1038/s41375-018-0122-0 pubmed: 29725032 pmcid: 6127086
Ratajczak, M. Z., & Kucia, M. (2021). Extracellular adenosine triphosphate (eATP) and its metabolite, extracellular adenosine (eAdo), as opposing “Yin-Yang” regulators of Nlrp3 inflammasomein the trafficking of hematopoietic stem/progenitor cells. Frontiers in Immunology, 11, 603942.
doi: 10.3389/fimmu.2020.603942 pubmed: 33584673 pmcid: 7878390

Auteurs

Kamila Bujko (K)

Department of Regenerative Medicine, Center for Preclinical Studies and Technology, Warsaw Medical University, Warsaw, Poland.

Katarzyna Brzezniakiewicz-Janus (K)

Department of Hematology, University of Zielona Gora, Multi-Specialist Hospital Gorzow Wlkp., Zielona Gora, Poland.

Justyna Jarczak (J)

Department of Regenerative Medicine, Center for Preclinical Studies and Technology, Warsaw Medical University, Warsaw, Poland.

Magdalena Kucia (M)

Department of Regenerative Medicine, Center for Preclinical Studies and Technology, Warsaw Medical University, Warsaw, Poland. magdalena.kucia@wum.edu.pl.

Mariusz Z Ratajczak (MZ)

Department of Regenerative Medicine, Center for Preclinical Studies and Technology, Warsaw Medical University, Warsaw, Poland. mzrata01@louisville.edu.
Stem Cell Institute at Graham Brown Cancer Center, University of Louisville, 500 S. Floyd Street, Rm. 107, Louisville, KY, 40202, USA. mzrata01@louisville.edu.

Classifications MeSH